[1] May K E, Villar J, Kirtley S, et al. Endometrial alterations in endometriosis: a systematic review of putative biomarkers [J]. Hum Reprod Update, 2011, 17(5): 637-653.
[2] Bedaiwy M A, Falcone T. Laboratory testing for endometriosis [J]. Clin Chim Acta, 2004, 340(1-2): 41-56.
[3] Yang W C, Chen H W, Au H K, et al. Serum and endometrial markers [J]. Best Pract Res Clin Obstet Gynaecol, 2004, 18(2): 305-318.
[4] Brosens J, Timmerman D, Starzinski-Powitz A, et al. Noninvasive diagnosis of endometriosis: the role of imaging and markers [J]. Obstet Gynecol Clin North Am, 2003, 30(1): 95-114, viii-ix.
[5] Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers [J]. Minerva Ginecol, 2006, 58(6): 527-551.
[6] Vodolazkaia A, Bossuyt X, Fassbender A, et al. A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis [J]. Reprod Biol Endocrinol, 2011, 9: 113.
[7] Pan Q, Chegini N. MicroRNA signature and regulatory functions in the endometrium during normal and disease states [J]. Semin Reprod Med, 2008, 26(6): 479-493.
[8] Wang W T, Zhao Y N, Han B W, et al. Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis [J]. J Clin Endocrinol Metab, 2013, 98(1): 281-289.
[9] Jia S Z, Yang Y, Lang J, et al. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis [J]. Hum Reprod, 2013, 28(2): 322-330.
[10] Ramon L A, Braza-Boils A, Gilabert-Estelles J, et al. microRNAs expression in endometriosis and their relation to angiogenic factors [J]. Hum Reprod, 2011, 26(5): 1082-1090.
[11] Dai L, Gu L, Di W. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKbeta/NF-kappaB pathway and reduced interleukin-8 expression [J]. Mol Hum Reprod, 2012, 18(3): 136-145.
[12] Petracco R, Grechukhina O, Popkhadze S, et al. MicroRNA 135 regulates HOXA10 expression in endometriosis [J]. J Clin Endocrinol Metab, 2011, 96(12): E1925-E1933.
[13] Zhao Z Z, Croft L, Nyholt D R, et al. Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis [J]. Mol Hum Reprod, 2011, 17(2): 92-103.
[14] Barcz E, Milewski L, Dziunycz P, et al. Peritoneal cytokines and adhesion formation in endometriosis: an inverse association with vascular endothelial growth factor concentration [J]. Fertil Steril, 2012, 97(6): 1380-1386.
[15] Ulukus M, Ulukus E C, Tavmergen Goker E N, et al. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis [J]. Fertil Steril, 2009, 91(3): 687-693.
[16] Seo S K, Yang H I, Lee K E, et al. The roles of thioredoxin and thioredoxin-binding protein-2 in endometriosis [J]. Hum Reprod, 2010, 25(5): 1251-1258.
[17] Kim K H, Lee E N, Park J K, et al. Curcumin attenuates TNF-alpha-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells [J]. Phytother Res, 2012, 26(7): 1037-1047.
[18] Mohamed M L, El Behery M M, Mansour S A. Comparative study between VEGF-A and CA125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery [J]. Arch Gynecol Obstet, 2013, 287(1): 77-82.
[19] Jana S, Rudra D S, Paul S, et al. Curcumin delays endometriosis development by inhibiting MMP-2 activity [J]. Indian J Biochem Biophys, 2012, 49(5): 342-348.
[20] Kim J H, Yang Y I, Ahn J H, et al. Deer (Cervus elaphus) antler extract suppresses adhesion and migration of endometriotic cells and regulates MMP-2 and MMP-9 expression [J]. J Ethnopharmacol, 2012, 140(2): 391-397.
[21] Matsuzaki S, Maleysson E, Darcha C. Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis [J]. Hum Reprod, 2010, 25(3): 742-750.
[22] Nasu K, Kawano Y, Tsukamoto Y, et al. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target [J]. J Obstet Gynaecol Res, 2011, 37(7): 683-695.
[23] Wu Y, Halverson G,Basir Z, et al. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis [J]. Am J Obstet Gynecol, 2005, 193(2): 371-380.
[24] Guo S W. Epigenetics of endometriosis [J]. Mol Hum Reprod, 2009, 15(10): 587-607.
[25] Brosens I, Puttemans P, Campo R, et al. Non-invasive methods of diagnosis of endometriosis [J]. Curr Opin Obstet Gynecol, 2003, 15(6): 519-522.
[26] Xue Q, Zhou Y F, Zhu S N, et al. Hypermethylation of the CpG island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis [J]. Reprod Sci, 2011, 18(11): 1080-1084.
[27] Xue Q, Lin Z, Cheng Y H, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis [J]. Biol Reprod, 2007, 77(4): 681-687.
